世界の腫瘍溶解性ウイルス薬物治療市場予測2023-2029:フェーズ1、フェーズ2、その他

【英語タイトル】Oncolytic Virus Drug Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2496)・商品コード:MMG23FB2496
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:61
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の腫瘍溶解性ウイルス薬物治療市場規模と予測を収録しています。・世界の腫瘍溶解性ウイルス薬物治療市場:売上、2018年-2023年、2024年-2029年
・世界の腫瘍溶解性ウイルス薬物治療市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腫瘍溶解性ウイルス薬物治療市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「フェーズ1」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

腫瘍溶解性ウイルス薬物治療のグローバル主要企業は、Amgen、Oncolytics Biotech、Viralytics、Transgene SA、Oncolys BioPharma、Targovax、PsiOxus Therapeutics、SillaJen Biotherapeutics、Sorrento Therapeutics、Lokon Pharma、Genelux Corporation、Vyriad、TILT Biotherapeutics、Cold Genesysなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、腫瘍溶解性ウイルス薬物治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の腫瘍溶解性ウイルス薬物治療市場:タイプ別、2018年-2023年、2024年-2029年
世界の腫瘍溶解性ウイルス薬物治療市場:タイプ別市場シェア、2022年
・フェーズ1、フェーズ2、その他

世界の腫瘍溶解性ウイルス薬物治療市場:用途別、2018年-2023年、2024年-2029年
世界の腫瘍溶解性ウイルス薬物治療市場:用途別市場シェア、2022年
・黒色腫、前立腺がん、乳がん、卵巣がん、その他

世界の腫瘍溶解性ウイルス薬物治療市場:地域・国別、2018年-2023年、2024年-2029年
世界の腫瘍溶解性ウイルス薬物治療市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における腫瘍溶解性ウイルス薬物治療のグローバル売上、2018年-2023年
・主要企業における腫瘍溶解性ウイルス薬物治療のグローバル売上シェア、2022年
・主要企業における腫瘍溶解性ウイルス薬物治療のグローバル販売量、2018年-2023年
・主要企業における腫瘍溶解性ウイルス薬物治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Amgen、Oncolytics Biotech、Viralytics、Transgene SA、Oncolys BioPharma、Targovax、PsiOxus Therapeutics、SillaJen Biotherapeutics、Sorrento Therapeutics、Lokon Pharma、Genelux Corporation、Vyriad、TILT Biotherapeutics、Cold Genesys

*************************************************************

・調査・分析レポートの概要
腫瘍溶解性ウイルス薬物治療市場の定義
市場セグメント
世界の腫瘍溶解性ウイルス薬物治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腫瘍溶解性ウイルス薬物治療市場規模
世界の腫瘍溶解性ウイルス薬物治療市場規模:2022年 VS 2029年
世界の腫瘍溶解性ウイルス薬物治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腫瘍溶解性ウイルス薬物治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腫瘍溶解性ウイルス薬物治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:フェーズ1、フェーズ2、その他
腫瘍溶解性ウイルス薬物治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:黒色腫、前立腺がん、乳がん、卵巣がん、その他
腫瘍溶解性ウイルス薬物治療の用途別グローバル売上・予測

・地域別市場分析
地域別腫瘍溶解性ウイルス薬物治療市場規模 2022年と2029年
地域別腫瘍溶解性ウイルス薬物治療売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Amgen、Oncolytics Biotech、Viralytics、Transgene SA、Oncolys BioPharma、Targovax、PsiOxus Therapeutics、SillaJen Biotherapeutics、Sorrento Therapeutics、Lokon Pharma、Genelux Corporation、Vyriad、TILT Biotherapeutics、Cold Genesys

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Oncolytic Virus Drug Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncolytic Virus Drug Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncolytic Virus Drug Treatment Overall Market Size
2.1 Global Oncolytic Virus Drug Treatment Market Size: 2022 VS 2029
2.2 Global Oncolytic Virus Drug Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncolytic Virus Drug Treatment Players in Global Market
3.2 Top Global Oncolytic Virus Drug Treatment Companies Ranked by Revenue
3.3 Global Oncolytic Virus Drug Treatment Revenue by Companies
3.4 Top 3 and Top 5 Oncolytic Virus Drug Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncolytic Virus Drug Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncolytic Virus Drug Treatment Players in Global Market
3.6.1 List of Global Tier 1 Oncolytic Virus Drug Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncolytic Virus Drug Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Oncolytic Virus Drug Treatment Market Size Markets, 2022 & 2029
4.1.2 Phase 1
4.1.3 Phase 2
4.1.4 Others
4.2 By Type – Global Oncolytic Virus Drug Treatment Revenue & Forecasts
4.2.1 By Type – Global Oncolytic Virus Drug Treatment Revenue, 2018-2023
4.2.2 By Type – Global Oncolytic Virus Drug Treatment Revenue, 2024-2029
4.2.3 By Type – Global Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oncolytic Virus Drug Treatment Market Size, 2022 & 2029
5.1.2 Melanoma
5.1.3 Prostate Cancer
5.1.4 Breast Cancer
5.1.5 Ovarian Cancer
5.1.6 Others
5.2 By Application – Global Oncolytic Virus Drug Treatment Revenue & Forecasts
5.2.1 By Application – Global Oncolytic Virus Drug Treatment Revenue, 2018-2023
5.2.2 By Application – Global Oncolytic Virus Drug Treatment Revenue, 2024-2029
5.2.3 By Application – Global Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Oncolytic Virus Drug Treatment Market Size, 2022 & 2029
6.2 By Region – Global Oncolytic Virus Drug Treatment Revenue & Forecasts
6.2.1 By Region – Global Oncolytic Virus Drug Treatment Revenue, 2018-2023
6.2.2 By Region – Global Oncolytic Virus Drug Treatment Revenue, 2024-2029
6.2.3 By Region – Global Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Oncolytic Virus Drug Treatment Revenue, 2018-2029
6.3.2 US Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.3.3 Canada Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.3.4 Mexico Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Oncolytic Virus Drug Treatment Revenue, 2018-2029
6.4.2 Germany Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.4.3 France Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.4.4 U.K. Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.4.5 Italy Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.4.6 Russia Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.4.8 Benelux Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Oncolytic Virus Drug Treatment Revenue, 2018-2029
6.5.2 China Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.5.3 Japan Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.5.4 South Korea Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.5.6 India Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Oncolytic Virus Drug Treatment Revenue, 2018-2029
6.6.2 Brazil Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.6.3 Argentina Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Oncolytic Virus Drug Treatment Revenue, 2018-2029
6.7.2 Turkey Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.7.3 Israel Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Oncolytic Virus Drug Treatment Market Size, 2018-2029
6.7.5 UAE Oncolytic Virus Drug Treatment Market Size, 2018-2029
7 Oncolytic Virus Drug Treatment Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Oncolytic Virus Drug Treatment Major Product Offerings
7.1.4 Amgen Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Oncolytics Biotech
7.2.1 Oncolytics Biotech Company Summary
7.2.2 Oncolytics Biotech Business Overview
7.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Major Product Offerings
7.2.4 Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.2.5 Oncolytics Biotech Key News & Latest Developments
7.3 Viralytics
7.3.1 Viralytics Company Summary
7.3.2 Viralytics Business Overview
7.3.3 Viralytics Oncolytic Virus Drug Treatment Major Product Offerings
7.3.4 Viralytics Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.3.5 Viralytics Key News & Latest Developments
7.4 Transgene SA
7.4.1 Transgene SA Company Summary
7.4.2 Transgene SA Business Overview
7.4.3 Transgene SA Oncolytic Virus Drug Treatment Major Product Offerings
7.4.4 Transgene SA Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.4.5 Transgene SA Key News & Latest Developments
7.5 Oncolys BioPharma
7.5.1 Oncolys BioPharma Company Summary
7.5.2 Oncolys BioPharma Business Overview
7.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Major Product Offerings
7.5.4 Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.5.5 Oncolys BioPharma Key News & Latest Developments
7.6 Targovax
7.6.1 Targovax Company Summary
7.6.2 Targovax Business Overview
7.6.3 Targovax Oncolytic Virus Drug Treatment Major Product Offerings
7.6.4 Targovax Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.6.5 Targovax Key News & Latest Developments
7.7 PsiOxus Therapeutics
7.7.1 PsiOxus Therapeutics Company Summary
7.7.2 PsiOxus Therapeutics Business Overview
7.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Major Product Offerings
7.7.4 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.7.5 PsiOxus Therapeutics Key News & Latest Developments
7.8 SillaJen Biotherapeutics
7.8.1 SillaJen Biotherapeutics Company Summary
7.8.2 SillaJen Biotherapeutics Business Overview
7.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Major Product Offerings
7.8.4 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.8.5 SillaJen Biotherapeutics Key News & Latest Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Company Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Major Product Offerings
7.9.4 Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.9.5 Sorrento Therapeutics Key News & Latest Developments
7.10 Lokon Pharma
7.10.1 Lokon Pharma Company Summary
7.10.2 Lokon Pharma Business Overview
7.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Major Product Offerings
7.10.4 Lokon Pharma Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.10.5 Lokon Pharma Key News & Latest Developments
7.11 Genelux Corporation
7.11.1 Genelux Corporation Company Summary
7.11.2 Genelux Corporation Business Overview
7.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Major Product Offerings
7.11.4 Genelux Corporation Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.11.5 Genelux Corporation Key News & Latest Developments
7.12 Vyriad
7.12.1 Vyriad Company Summary
7.12.2 Vyriad Business Overview
7.12.3 Vyriad Oncolytic Virus Drug Treatment Major Product Offerings
7.12.4 Vyriad Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.12.5 Vyriad Key News & Latest Developments
7.13 TILT Biotherapeutics
7.13.1 TILT Biotherapeutics Company Summary
7.13.2 TILT Biotherapeutics Business Overview
7.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Major Product Offerings
7.13.4 TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.13.5 TILT Biotherapeutics Key News & Latest Developments
7.14 Cold Genesys
7.14.1 Cold Genesys Company Summary
7.14.2 Cold Genesys Business Overview
7.14.3 Cold Genesys Oncolytic Virus Drug Treatment Major Product Offerings
7.14.4 Cold Genesys Oncolytic Virus Drug Treatment Revenue in Global Market (2018-2023)
7.14.5 Cold Genesys Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Oncolytic Virus Drug Treatment Market Opportunities & Trends in Global Market
Table 2. Oncolytic Virus Drug Treatment Market Drivers in Global Market
Table 3. Oncolytic Virus Drug Treatment Market Restraints in Global Market
Table 4. Key Players of Oncolytic Virus Drug Treatment in Global Market
Table 5. Top Oncolytic Virus Drug Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncolytic Virus Drug Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncolytic Virus Drug Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncolytic Virus Drug Treatment Product Type
Table 9. List of Global Tier 1 Oncolytic Virus Drug Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncolytic Virus Drug Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Oncolytic Virus Drug Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncolytic Virus Drug Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Oncolytic Virus Drug Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncolytic Virus Drug Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Oncolytic Virus Drug Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncolytic Virus Drug Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Oncolytic Virus Drug Treatment Product Offerings
Table 32. Amgen Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Oncolytics Biotech Company Summary
Table 35. Oncolytics Biotech Oncolytic Virus Drug Treatment Product Offerings
Table 36. Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Oncolytics Biotech Key News & Latest Developments
Table 38. Viralytics Company Summary
Table 39. Viralytics Oncolytic Virus Drug Treatment Product Offerings
Table 40. Viralytics Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Viralytics Key News & Latest Developments
Table 42. Transgene SA Company Summary
Table 43. Transgene SA Oncolytic Virus Drug Treatment Product Offerings
Table 44. Transgene SA Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Transgene SA Key News & Latest Developments
Table 46. Oncolys BioPharma Company Summary
Table 47. Oncolys BioPharma Oncolytic Virus Drug Treatment Product Offerings
Table 48. Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Oncolys BioPharma Key News & Latest Developments
Table 50. Targovax Company Summary
Table 51. Targovax Oncolytic Virus Drug Treatment Product Offerings
Table 52. Targovax Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Targovax Key News & Latest Developments
Table 54. PsiOxus Therapeutics Company Summary
Table 55. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product Offerings
Table 56. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. PsiOxus Therapeutics Key News & Latest Developments
Table 58. SillaJen Biotherapeutics Company Summary
Table 59. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product Offerings
Table 60. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. SillaJen Biotherapeutics Key News & Latest Developments
Table 62. Sorrento Therapeutics Company Summary
Table 63. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product Offerings
Table 64. Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Sorrento Therapeutics Key News & Latest Developments
Table 66. Lokon Pharma Company Summary
Table 67. Lokon Pharma Oncolytic Virus Drug Treatment Product Offerings
Table 68. Lokon Pharma Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Lokon Pharma Key News & Latest Developments
Table 70. Genelux Corporation Company Summary
Table 71. Genelux Corporation Oncolytic Virus Drug Treatment Product Offerings
Table 72. Genelux Corporation Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Genelux Corporation Key News & Latest Developments
Table 74. Vyriad Company Summary
Table 75. Vyriad Oncolytic Virus Drug Treatment Product Offerings
Table 76. Vyriad Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Vyriad Key News & Latest Developments
Table 78. TILT Biotherapeutics Company Summary
Table 79. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product Offerings
Table 80. TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. TILT Biotherapeutics Key News & Latest Developments
Table 82. Cold Genesys Company Summary
Table 83. Cold Genesys Oncolytic Virus Drug Treatment Product Offerings
Table 84. Cold Genesys Oncolytic Virus Drug Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Cold Genesys Key News & Latest Developments
List of Figures
Figure 1. Oncolytic Virus Drug Treatment Segment by Type in 2022
Figure 2. Oncolytic Virus Drug Treatment Segment by Application in 2022
Figure 3. Global Oncolytic Virus Drug Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncolytic Virus Drug Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oncolytic Virus Drug Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncolytic Virus Drug Treatment Revenue in 2022
Figure 8. By Type - Global Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 16. US Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 28. China Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Oncolytic Virus Drug Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Oncolytic Virus Drug Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Viralytics Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Transgene SA Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Targovax Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lokon Pharma Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Genelux Corporation Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Vyriad Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Cold Genesys Oncolytic Virus Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の腫瘍溶解性ウイルス薬物治療市場予測2023-2029:フェーズ1、フェーズ2、その他] (コード:MMG23FB2496)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の腫瘍溶解性ウイルス薬物治療市場予測2023-2029:フェーズ1、フェーズ2、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆